FDA Inspection 1091493 — Aurore Perrot, MCU-PH
The FDA completed an inspection of Aurore Perrot, MCU-PH on May 3, 2019 in Meurthe-Et-Moselle. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 3, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Meurthe-Et-Moselle (France)
Additional Details
Clinical Investigator (CI)